Web Results

Dexrazoxane - Wikipedia

en.wikipedia.org/wiki/Dexrazoxane

Dexrazoxane hydrochloride is a cardioprotective agent. It was discovered by Kurt Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended ...

Dexrazoxane Injection: MedlinePlus Drug Information

medlineplus.gov/druginfo/meds/a609010.html

Nov 15, 2015 ... Dexrazoxane Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Zinecard (dexrazoxane for injection) - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2012/020212s013lbl.pdf

ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended for intravenous administration. It is a cardioprotective agent for use in ...

Totect, Zinecard (dexrazoxane) dosing, indications, interactions ...

reference.medscape.com/drug/totect-zinecard-dexrazoxane-342250

Medscape - Indication-specific dosing for Totect, Zinecard (dexrazoxane), frequency-based adverse effects, comprehensive interactions, contraindications,  ...

Dexrazoxane - FDA prescribing information, side effects and uses

www.drugs.com/pro/dexrazoxane.html

Dexrazoxane official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

Zinecard (Dexrazoxane): Side Effects, Interactions, Warning ... - RxList

www.rxlist.com/zinecard-drug.htm

Nov 28, 2016 ... ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended for intravenous administration. It is a cardioprotective ...

Dexrazoxane - DrugBank

www.drugbank.ca/drugs/DB00380

Jun 13, 2005 ... Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a ...

Dexrazoxane : a review of its use for cardioprotection during ... - NCBI

www.ncbi.nlm.nih.gov/pubmed/15892593

Drugs. 2005;65(7):1005-24. Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy. Cvetković RS(1), Scott LJ.

Anthracycline extravasation injuries: management with dexrazoxane

www.ncbi.nlm.nih.gov/pmc/articles/PMC2697522/

May 20, 2009 ... Dexrazoxane (ICRF-187) can be considered to be a neutral pro-drug analogue to the tetra-acid metal chelator EDTA. Chemically, dexrazoxane ...

Dexrazoxane: new indication. Anthracycline extravasation: continue ...

www.ncbi.nlm.nih.gov/pubmed/19382398

Prescrire Int. 2009 Feb;18(99):6-8. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide. [No authors listed].

More Info

FDA Approval for Dexrazoxane Hydrochloride - National Cancer ...

www.cancer.gov

Jul 2, 2013 ... On September 6, 2007, the FDA approved dexrazoxane hydrochloride for injection (Totect™ made by TopoTarget USA, Inc.), equivalent to 500 ...

Dexrazoxane - Drug Information - Chemocare

chemocare.com

Zinecard is the trade name for dexrazoxane. In some cases, health care professionals may use the trade name zinecard when referring to the generic drug name ...

Dexrazoxane: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com

Easy to read patient leaflet for dexrazoxane. Includes indications, proper use, special instructions, precautions, and possible side effects.